This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
We identify safer crypto choices for newcomers, covering safety features, liquidity signals, and a starter framework.
18,936 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Your budget should guide your money, not trip you up. Learn actionable steps to fix errors in your personal budget, r...
A cross-chain breach targeting the Verus-Ethereum bridge drained more than $11 million, triggering renewed focus on s...
Synopsys stock faces near-term headwinds despite rising revenue, as margins and debt weigh on the long-term outlook. ...
The Long Island Rail Road remains shut down as a sweeping strike stretches into a second day, affecting roughly 250,0...
Prices may look flat, but the real bill for home buying in 2026 is higher. This guide reveals where data lies, what b...
Hive Digital Technologies jumped 34% and T1 Energy rose 20% as traders chased chatter around Leopold Aschenbrenner’s ...
July 16 could be a pivotal date for Nvidia and the broader AI chip ecosystem. This guide explains why Nvidia investor...
Retirees seeking reliable, recurring income can benefit from a small, focused trio of high-yielding dividend stocks. ...
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
While tech and AI grab headlines, other parts of the market are quietly delivering solid results. This piece explores...
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...